Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Jessica Mitacek

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?

Shares of telehealth provider Hims & Hers Health (NYSE: HIMS) sold off sharply following disappointing Q1 FY2026 financial results, with shares falling more than 12% in after-hours trading after the company reported on May 11.

Expectations for the quarter were high, particularly after partnering with Danish multinational pharmaceutical company Novo Nordisk (NYSE: NVO).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.